Where is Vivozon located?

Vivozon is headquartered in West Windsor Township, United States.

How many employees does Vivozon have?

As of Jul 31, 2026, the latest employee count at Vivozon is 11.

Where does Vivozon rank among its competitors?

Vivozon ranks 678th amongst 2745 active competitors, of which 916 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Immuneel, which secured $10.5M in Jun, 2026.

Who are the top competitors of Vivozon?

Vivozon's top competitors include Jazz Pharmaceuticals, Sana Biotechnology and argenx. Among them, Immuneel secured the most recent funding round in June, 2026.

Vivozon - 2026 Company Profile & Competitors

Vivozon is an unfunded company based in West Windsor Township (United States), founded in 2008. It operates as an Innovative drug discovery and development company focused on pain and CNS diseases. Vivozon has not raised any funding yet. The company has 2745 active competitors, including 916 funded and 691 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, Sana Biotechnology and argenx.

Company Details

Innovative drug discovery and development company focused on pain and CNS diseases. They develop new drugs through progressive thinking and solid scientific foundations, striving for health, well-being, and happiness. Experts in new drug development work together to ensure these goals. The company focuses on novel drug candidates for pain and central nervous system diseases, developing new chemical drugs that act on multi-targets to create synergistic efficacy. They apply efficacy-based screening from the early stage of discovery to derive candidate substances with high potential for successful clinical trials and continue with global clinical development. Their core competencies lie in chemistry, biology, and clinical research, driving them to the forefront of innovative medicine.

Website: vivozon.com
Email ID: *****@vivozon.com
Phone Number: +1 **********

Key Metrics

Founded Year

2008

Location

West Windsor Township, United States

Stage

Unfunded

Ranked

678^th among 2745 active competitors

Employee Count

11 as on Jul 31, 2026

Investment & Acquisitions

Emmaus Medical

Similar Companies

Heron Therapeutics & 311 more

View Vivozon's full profile

Vivozon has not raised any funding rounds yet.

Vivozon's employee count trend

Vivozon has 11 employees as of Jul 26. Here is Vivozon's employee count trend over the years:

Uncover Vivozon's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Vivozon include Jazz Pharmaceuticals, Sana Biotechnology and argenx. Here is the list of Top 10 competitors of Vivozon, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jazz Pharmaceuticals 2003, Dublin (Ireland), Public	Developer of novel biopharmaceutical medicines for unmet medical needs	$265M	Versant Ventures, Prospect Venture Partners ... & 14 others	82/100
2nd	Sana Biotechnology 2018, Seattle (United States), Public	Developer of engineered cell therapies for treating various human diseases	$821M	Baillie Gifford, Google Ventures & 17 others	75/100
3rd	argenx 2008, Ghent (Belgium), Public	Developer of antibody-based drugs to treat autoimmune diseases and cancer	$61.9M	Life Sciences Partners, Seventure Partners ... & 20 others	74/100
4th	Ideaya Biosciences 2015, San Francisco (United States), Public	Developer of oncology-focused precision medicine using molecular diagnostics	$157M	BVF Partners, Boxer Capital & 15 others	72/100
5th	Sutro Biopharma 2003, United States, Public	Developer of antibody-based therapeutics for cancer therapy	$175M	Skyline Ventures, Alta Partners & 17 others	72/100
6th	Syndax 2005, Waltham (United States), Public	Developer of targeted therapies for the treatment of cancer	$198M	Fidelity Investments, Domain Associates & 19 others	72/100
7th	Karyopharm 2008, Newton (United States), Public	Biopharmaceutical company focused on developing and commercializing innovative cancer therapies	$98.4M	Foresite Capital, Avidity Partners & 16 others	71/100
8th	C4 Therapeutics 2016, Cambridge (United States), Public	Developer of small molecule drugs for treating cancer	$223M	Cobro Ventures, Perceptive Advisors & 27 others	71/100
9th	Immuneel 2018, Bengaluru (India), Series B	Developer of T-cell therapies for the treatment of cancer	$49.8M	True North, F-Prime Capital & 23 others	71/100
10th	Zymeworks 2003, Vancouver (Canada), Public	Developer of bi-specific antibodies & antibody-drug conjugates to treat cancer	$146M	CTI Life Sciences Fund, Advanced Biotechnologies Venture Fund ... & 17 others	71/100
678th	Vivozon 2008, West Windsor Township (United States), Unfunded	Innovative drug discovery and development company focused on pain and CNS diseases	-	-	33/100